Why the study?
Does the combination of aspirin and heparin increase total mortality and bleeding complications compared to heparin alone in patients receiving thrombo-prophylaxis?
Does the combination of aspirin and heparin increase total mortality and bleeding complications compared to heparin alone in patients receiving thrombo-prophylaxis?
Answers are grounded in this paper and cite their sources.
Adding aspirin to heparin for venous thrombo-prophylaxis may increase total mortality and bleeding complications, outweighing the benefits of reduced pulmonary embolism.
Antiplatelet prophylaxisCombination treatment may cause bleeding EDITOR,-The Antiplatelet Trialists' Collaboration has carried out an important meta-analysis of antiplatelet prophylaxis used to reduce venous thrombosis and pulmonary embolism.'The results section of the abstract of the paper states: "Information on adding antiplatelet therapy to heparin was limited but, at least for pulmonary embolism, suggested more protection from the combination than from heparin alone."We suggest that consideration should be given to possible harmful effects of the combination of aspirin and heparin.The authors found a 62 (SD 33)% reduction in the odds of pulmonary embolism after the combined treatment compared with the same dose of heparin.They also noted a 12 (22)% reduction in the odds of deep vein thrombosis.They do not, however, present any comparisons of total mortality or of complications.We therefore made these comparisons, using data from individual trials given in appendix 1.We found that total mortality was higher with combination treatment than with heparin alone (table).Although this increase was not significant (neither was the reported reduction in pulmonary embolism), it is worrying when considered together with the much higher rate of complications related to bleeding after the combination treatment.In absolute terms the possible benefits of combination treatment could well be overturned by the possible harmful effects.There was a reduction of 0-6 cases of non-fatal pulmonary embolism per 100 patients allocated combination treatment but an increase of 0 9 deaths (all causes) and 4 0 complications related to bleeding per 100.These results highlight the importance of considering total mortality in any comparison of treatments and emphasise the need for caution in using this combination treatment for thrombo- prophylaxis.Nevertheless, we do not wish to detract from the importance of the results that were presented and the potential benefits of using aspirin on its own.
No takes yet. Share an insight, caveat, or question.
Seagroatt et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: